The market has been high on Inmode Ltd (INMD) stock recently. INMD gets a Bullish score from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With INMD Stock Today?
Inmode Ltd (INMD) stock has gained 5.46% while the S&P 500 has fallen -0.25% as of 2:19 PM on Tuesday, Mar 2. INMD has gained $3.95 from the previous closing price of $72.30 on volume of 1,116,068 shares. Over the past year the S&P 500 is higher by 25.94% while INMD has gained 131.13%. INMD earned $1.78 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 42.95.
To see the top 5 stocks in the Medical Devices industry click here.
More About Inmode Ltd
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, Evolve, Evoke, and Morpheus8. The majority of its revenue comes from the United States.
Click Here to get the full Stock Score Report on Inmode Ltd (INMD) Stock.
